This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.
spk05: Good morning and welcome to the Central Technologies Corporation 2023 first quarter earnings conference call. All participants will be in listen-only mode. Should you need assistance, please call a conference specialist by pressing the star key followed by zero. After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press star then one on your touch-tone phone. To withdraw your question, please press star then two. Please note, this event is being recorded. I would now like to turn the conference over to Mr. Steve Rolfs. Please go ahead, sir.
spk00: Good morning. Welcome to Sentient's earnings call for the first quarter of 2023. I'm Steve Rolfs, Senior Vice President and Chief Financial Officer of Sentient Technologies Corporation. I am joined today by Paul Manning, Sentient's Chairman, President, and Chief Executive Officer. Earlier today, we released our 2023 first quarter results. A copy of the release and our investor presentation is available on our website at sentient.com. During our call today, we will reference certain non-GAAP financial measures which remove the impact of currency movements and other items as noted in the company's filings. We believe the removal of these items provides investors with additional information to evaluate the company's performance and improves the comparability of results between reporting periods. This also reflects how management reviews and evaluates the company's operations and performance. Non-GAAP financial results should not be considered in isolation from or as a substitute for financial information calculated in accordance with GAAP. A reconciliation of non-GAAP financial measures to the most directly comparable GAAP financial measures is available in our press release, We encourage investors to review these reconciliations in connection with the comments we make today. I would also like to remind everyone that comments made this morning, including responses to your questions, may include forward-looking statements. Our actual results may differ materially from those that may be expressed or implied due to a wide range of factors, including those set forth in our SEC filings. We urge you to read Censian's previous SEC filings, including our 10-K and our forthcoming 10-Q, for a description of additional factors that could potentially impact our financial results. Please keep these factors in mind when you analyze our comments today. Now we'll hear from Paul Manning. Thanks, Steve.
spk04: Good morning and good afternoon. Censian's local currency revenue increased by 5% during the first quarter. We saw good top-line growth across most of our businesses with strong sales wins and effective pricing implementation. We are on track to deliver against our full-year guidance. As expected, and as we discussed last quarter, we continue to see destocking across the company. The impact was most pronounced in the flavors and extracts group and in the North American market. Additionally, we began to experience a decrease in customer order lead times as customers reverted back to pre-pandemic order timing and inventory levels. While our customers are going through a temporary effort to normalize their inventory levels, we are still seeing strong product development activity. We are maintaining our strong new sales winds and our sales pipeline remains robust. We expect good product launch activity for the balance of the year And this is a good development given last year's low product launch activity in the market. As the stocking moderates in the back half of the year, we expect incremental revenue improvement. Our new sales win rates continue to remain high across all three groups. In 2022, we had one of our best years in terms of new sales wins, despite a decline in new product market launches in many parts of the world. In the first quarter of 2023, our new win rate continued to be at this very high level. We continue to win new business based on our focus on sales execution, our outstanding customer service, and our broad product portfolio. We continue to achieve these new sales wins across all product lines and throughout most of our geographic regions. Also during the first quarter this year, we have continued to implement pricing in an effort to overcome the ongoing inflation. While supply chains and the raw material cost outlook may be improving in some areas, overall, we continue to experience elevated energy and commodity costs in certain geographic regions. As we discussed last quarter, the timing of our pricing actions versus the timing of cost inflation may distort our quarterly year-over-year performance, and as a result, we believe our full-year results will be the best indication of our performance. Now turning to the groups. The color group had a strong first quarter, delivering 10% local currency revenue growth and more than 6% local currency operating profit growth. The group's revenue growth benefited from a low double-digit price increase which was partially offset by an approximately mid-single-digit revenue headwind due to destocking. The food and pharmaceutical product line delivered 16 percent local currency revenue growth with solid volume growth. The food and pharmaceutical product lines are delivering a high level of new sales wins as a result of our innovative natural color portfolio and strong customer service. The magnitude of these wins has more than offset any customer destocking. The personal care product line revenue was down low single digits in the first quarter, primarily due to customer destocking, mainly in North America, and tough prior year comparisons. We expect personal care growth rates to resume in the back half of the year. I continue to expect the color group to deliver mid-single digit revenue growth and mid to high single digit local currency operating profit growth. We believe food and pharmaceutical colors will have solid growth throughout 2023 and beyond. Personal care will continue to struggle in the second quarter, but will have improved results in the second half of the year. The flavors and extracts group was down approximately 1% in local currency revenue during the quarter. The group's strong win rate and pricing were offset by customer destocking and ongoing market downturn in most product categories in North America. As mentioned during our last call, destocking largely began in the fourth quarter of 2022. Within this first quarter of 2023, we continued to experience destocking, most notably in natural ingredients and our traditional flavor categories. In some cases, these destocking activities were quite dramatic in the quarter. We believe that once our customers' inventory levels and order patterns begin to normalize, the flavors and extracts group should resume its mid-single-digit growth profile in the back half of 2023. For the year, I now expect the flavors and extracts group to deliver mid-single-digit revenue growth and low single-digit operating profit growth. The Asia-Pacific group continued the strong performance achieved over the last several years. In the first quarter, the group delivered 15% local currency revenue growth and 18% local currency operating profit growth. The group is not experiencing the destocking impact that the color group and the flavors and extract groups are experiencing. The Asia-Pacific group continues to benefit from strong new winds across almost all regions. The group's focus on sales execution and customer service, as well as the investments we have made in the region, are fueling the group's current growth and we believe position the group nicely for continued growth. Asia Pacific is a good example of our ability to shift our sales mix to higher margin specialty products and to deliver higher quality defensible sales wins. I continue to expect the Asia Pacific group to deliver mid to high single digit revenue growth and mid to high single-digit operating profit growth in 2023. As we communicated during our fourth quarter call, we anticipated that destocking would continue into the first part of this year and that our quarterly performance would at times be distorted due to the inflationary environment. Overall, we have proven that our strategy supports solid growth across each of our businesses and our product portfolio is robust. We are focused on the levers we can control to grow our business. These include our focus on sales execution, our strong customer service, our broad product portfolio, and our strategic pricing initiatives. Overall, I'm excited about our opportunities within each of our businesses and remain optimistic about 2023 and the future of our business. Steve will now provide you with additional details on the first quarter results.
spk00: Thank you, Paul. Sentient's revenue was $369 million in the quarter compared to $355.5 million in last year's first quarter. Operating income was $50.8 million compared to $52.8 million in the comparable period last year. Foreign currency reduced revenue by approximately 1% and operating income by approximately 2% in the quarter. Interest expense was $6 million in this year's first quarter compared to $3 million in last year's first quarter. The company's consolidated tax rate was 24.9% in this year's first quarter compared to 25.6% in last year's first quarter. Diluted earnings per share were 80 cents in this year's first quarter compared to 88 cents in last year's first quarter. Foreign currency translation reduced EPS by approximately 2 cents. As discussed, we have begun to normalize our inventory levels. We have seen a decline in our March inventory level, and we plan to continue to manage our inventories down over the course of the year and should see improving cash flow as a result. Capital expenditures were $22 million in the first quarter of 2023. We expect our capital expenditures to be around $95 million for the year. Our net debt to credit-adjusted EBITDA is now $2.7 million. our balance sheet remains well-positioned to support our capital expenditures, sensible M&A, and our long-standing dividends. And any excess cash will be used to pay down debt. Regarding our 2023 guidance, we continue to expect our 2023 local currency revenue to be up mid-single digits compared to our 2022 revenue. And we continue to expect our local currency adjusted EBITDA to grow at a mid to high single digit rate in 2023. We also continue to expect our 2023 local currency EPS to be flat to up low single digits compared to our 2022 adjusted EPS of $3.29. As we have discussed, in 2023, our EPS will be impacted by higher interest expense and a higher tax rate. On a quarter-to-quarter basis, our tax rate will fluctuate, and therefore we continue to believe our local currency adjusted EBITDA growth is an important measure of our performance. Based on current exchange rates, we expect currency to be modestly favorable for the full year. Thank you for participating in the call today. We will now open the call for questions.
spk05: Thank you. We will now begin the question and answer session. To ask a question, you may press star, then 1 on your touchtone phone. To withdraw your question, please press star, then 2. At this time, we will pause momentarily to assemble our roster. And the first question will be from Gonsham Punjabi from Robert W. Baird. Please go ahead.
spk03: Thanks, and good morning, everyone. Morning, Gonsham. Morning. I guess first off on the color segment, you know, the outperformance in food and pharmaceutical, can you give us a sense as to whether the destocking dynamics that seem so pervasive across the rest of the portfolio and the supply chain, has that not had any sort of impact of significance for the food and pharma, and if so, Why do you think that is?
spk04: So I would say destocking, we saw it pretty much across the portfolio. Whether you're talking colors or flavors, it was obviously more pronounced, substantially more pronounced than flavors. You look at the overall colors, though, we had about a mid-single-digit headwind on destocking. I think what happened in food and pharma is they just won a lot of new business. And this is a continuing trend within the food and pharma segment for us. We've had a lot of successful efforts with respect to selling natural colors, but we also have had a lot of success in continuing to sell synthetic colors. So the short answer is, sure, there was destocking, about mid-single digits, but the win rate was very, very robust. They also very effectively managed price consistent with the need to maintain and perhaps even improve gross margins. So, yeah, they fundamentally just did a really great job at overcoming that destocking phenomenon.
spk03: Okay, great. And then I think you had called that good product activity expected for the year. Just maybe expand on that in context of what seems obvious, which is just a directional weakness in global consumer spending. And then related to that, I think you talked about destocking activities being quite dramatic in some categories. Just give us more color as to where exactly you saw that.
spk04: Okay. So on the product launch activity, yeah, this is a great thing to see. We saw it most notably in Europe. Europe, the new product launch activity was up about 10% in Q1. versus prior year. You may recall the first half of 2022, Europe's new product launches were down like mid-teens, like 14%, 15%. It got better in the second half and so left us with a slight decline in 2022. So the year started off very promising, particularly in the European market, but we're also seeing that trend of improving product launches in North America. So that is very very positive factor now the composition of the new launches this is something that we talked about I think it was the last call because folks are kind of interested what are you seeing so in Europe of those launches if you were to break that down by our estimates we see that as being about 40% of those launches are line extensions about a third of them would be truly new products and formulations And then the balance, which I guess would be about 25%, that's kind of more just a packaging change, which according to how these metrics are measured is also included in the realm of new launches. So that's a great, great sign there. And so I think we should expect, or I would like to say we should expect continued movement and improvement in that launch activity as the balance of the year unfolds. To your question about destocking, yeah, so I said in flavors it was rather dramatic. So if color said that sort of mid-single-digit headwind, 5% or 6%, in flavors it was about twice that. And I think the easiest way to talk about destocking, because it can obviously just be very confusing for folks, what do you mean destocking? Where is it happening? What are the themes? The themes that we see, I look at it in a couple of different ways. I look at by geography, I look at it as types of customers, and I look at it in terms of our business units. So with respect to geography, destocking was most pronounced in the U.S., followed by LATAM. I would say kind of a distant third would be Europe, and there was really none in Asia Pacific. Asia Pacific was up. The market was up from an organic standpoint. So that's one consideration for destocking. When you think about the types of customers where we saw destocking, broad-based, so Bs and Cs, locals, regionals, you saw it kind of in most parts of particularly the U.S. market, but most categories, most types of customers, but some of the larger multinationals. And, you know, we can certainly – see the popular press to see some of the announcements these companies made about reduction in inventory. In some cases, these multinationals reduced their order patterns by 30 to 40 percent. And so, as you can imagine, that could be a rather dramatic change in the order pattern. And then, you know, as you think about our business units, we saw this phenomenon. F&I, big impact there. Our bionutrients group, which sells principally into the probiotics market, big reduction there. Traditional flavors, particularly in beverage categories, big pullback there. In other words, big reduction in stock. And then, you know, certainly we saw that activity in our personal care, our cosmetics division. There was a fair amount of destocking, say mid, maybe even mid to high in certain regions. So that's kind of the magnitude. Now, I think we're going to see this destocking continue in Q2. But I see, you know, when your movements are that dramatic in some circles, you can imagine that the positive there is that they get through the destocking rather rapidly, which is good. Some of it may linger and languish for the balance of the year. But I think what you'll see in Q2, we'll still have some of this destocking headwind, perhaps about the magnitudes that you see here in Q1. But I think as you get to Q3, as we project in Q3, as we talk to our customers and canvas them, and that's really what you need to do here. Mr. Customer, you're destocking, okay, how much and for how long? And we literally canvas an enormous cross-section of customers, and we've concluded with a fair degree of confidence that we think by Q3, the destocking phenomenon, I'll be talking about it a heck of a lot less and in some cases not at all for certain regions and types of customers. So I think that should largely get at your question there on the destocking.
spk03: Yes, it did. Thanks so much.
spk04: Okay, sure thing.
spk05: And the next question will be from Heidi Vesterman from BNP Powerball. Please go ahead.
spk06: Morning. Hi, how are you? Following up on the stocking point, do you have visibility on where the excess stock is? Is it at customer level or could it be further down the chain, say, retailer level or even consumer level? And so, you know, what are your thoughts on that? And so, therefore, what visibility do you have on when this will actually end for the various segments?
spk04: Yeah, that's a great question. I asked a similar question, and here's the answers that we've come up with from our analysis. So if you think about some of those retailers, and let's just look at the U.S. market for a moment, the retailers you've heard of, the largest ones, as we've looked at this, largely have suggested that at the end of January, they were in a happy place with respect to inventory, whereas maybe they had run with 30 to 40 days pre-pandemic inventory, They might have, in some cases, got up to 40 to 50 days. But as we looked at their public filings and listened to their conference calls, we concluded and we heard them say that, in general, their inventory levels are kind of about where they want them to. So to your question, we don't see the inventory piled up at the retailer level. Now, as this moves down the supply chain, customers – So in some cases, you know, we had customers adding 10, 20 days in the course of the pandemic. So for example, uh, they might've had, uh, 30 days of inventory ice cream. That's a common category where customers, our types of customers would traditionally hold about 30 days during the pandemic. A lot of them went up to like 45 days on average. And so now they are in the program. This really kind of started in Q1 and we'll go into Q2. of taking out that three, and in some cases, four weeks of inventory. And so it's there right now. And then, of course, as a result, we have that reduction in orders from our customers. So I think a lot of it is at our customer level, the types of multinationals and even local regional brands that you're familiar with. At the end consumer level, We think most of that destocking took place early in 2022. You know, there's a finite amount of storage capacity. Okay, maybe Steve stores a bunch of stuff in his garage, but just about everybody else kind of ran through their stocks in the early part of 2022. So we don't really think there's a whole lot there. And so, in short, it's at our customers in a substantial way in some cases, but that moderated quite a bit in Q1, given some of those dramatic drop-offs.
spk06: And then the next question, perhaps on the margin in flavors and extracts, yeah, could you talk more about the drivers of the margin movement year on year? Was it primarily to do with negative volume leverage, or were there any sort of price-cost mismatch issues there, or any other factors? Thank you.
spk04: It's volume. Last year we had big volume. This year we had a lot less volume. And so, you know, you can see how that plays out financially. There was no appreciable change in our fixed cost structure. There was no appreciable change in our product mix. In fact, our product mix, I would argue, has improved even during Q1. Pricing, I think we were very effective in getting our pricing. We took just north of, you know, kind of low 10 to 11 percent pricing on average. So I think we can continue to say that we've been very, very effective. We're certainly covering our input costs, perhaps a bit more than that, on the road to maintaining gross margins. So the short answer is volume. So as destocking moderates, as these market launches continue, as the market in general in these categories continues to improve, I think you should see a much more robust and better volume output for the back half of the year, really across the sentient portfolio. So I think I feel very, very good about pricing. You know, folks talk about inflation moderating. Well, the overall inflation, as we see it, is moderating. So when you factor in things like energy and cars and construction, and that's correct. When you look at food inflation... As we measure food inflation and as we look at the sources of folks who measure food inflation, IRI and a lot of other European firms, we see food inflation in the mid-teens still in the U.S. and in Europe. So whereas energy may be coming down substantially and maybe it's 6% or 7%, food is still in this mid-teen inflation level. So it's a... I can't predict, and I've been trying not to predict, when inflation moderates, because it's hard to say when it will, but we will continue to address those input costs with pricing as needed.
spk06: Thanks. And I have one last one, unrelated actually to the Q1. Natural food colors. So, there was a recent discussion about Skittles being banned in California. Do you think we could see increased legislation-driven conversion from synthetic to natural colors? And would that sort of conversion be positive from a financial standpoint for sentience?
spk04: So, yeah, I'm certainly aware of the potential change in California. I think, in my opinion, that would just simply be the next item that has been banned in the state of California. So will that have a profound impact on customer behavior? Possibly. I would tell you we are very well aligned with the who's who of the industry. So if there are to be conversions as a consequence of that change in legislation, I would tell you that we are right up there and competing at every single one of those opportunities, as far as I would tell you. Could legislation... and maybe even broader than California, perhaps at the federal level, could that lead to changes in the market and accelerate natural colors? Possibly. Certainly, if the FDA did that, it would. But I'd like to remind folks that, in my opinion, food colors are the most regulated product in the entire world. Every batch of synthetic food colors has to be certified by the FDA. So that is a That would be a tough legislative change to make in the United States, in my opinion. Nevertheless, if it is, we're ready to meet the needs of our customers. But I think this will continue to be a market-driven phenomenon. The brands that have converted to natural colors have enjoyed a lot of success. It's good, positive messaging in many cases. And in other cases, it gives them an ability to overhaul their portfolio and their product lines. And so we see a lot of customers successfully implementing this. Of course, they do it in a way that the natural colors match the synthetic color shade that you're able to achieve. Efforts that fall short of that, they tend to not do as well. But could that be more beneficial to the company? Well, sure it would be. We would be selling a lot more volume if the portfolio converted from synthetic to natural. But we're interested in helping our customers be successful. And many customers have successfully launched products with synthetics. Others successfully launched products in natural. Our business is well above 50% natural colored now. So we are standing by and prepared to deal with any potential outcome there. But yeah, that could certainly be helpful
spk05: financially you could easily argue for us thank you okay thanks i again if you would like to ask a question please press star then one the next question is from mitra ramgopal from sudoti please go ahead yes hi good morning and thanks for taking the questions um hey paul um just wanted to if i listen to the tone here um
spk01: in terms of the outlook, things are lining up pretty nicely for you. I think that the stocking, as you mentioned, will be less of an issue in the second half of the year. You're having great success in terms of dealing with the input costs and pricing actions. You've launched new products. So a lot, very favorable. I'm just curious if, you know, what would you consider the potential like headwind for you as we take a longer term look on the company?
spk04: Well, you know, You've already cited the sort of shorter-term headwind in destocking the inflation. I'd like to think that longer-term inflation will not be a headwind, but it could be. And, you know, right now, consumers largely appear to be accepting these price increases, although certainly there are signs that folks are trading down or going to other options aside from some of the branded products. But I think, you know, longer term, we think there's just continued great opportunities for the company with respect to natural colors, which we just talked about with Heidi. The conversion within the personal care portfolio to more natural ingredients, very, very long-term technology-driven changes there I think will be very favorable to the company. the continued evolution of the flavors market to more extracts, extract-related solutions and taste modulation, removing sugar, things of that nature, all really, really positive factors. The headwinds, you know, competition is always a headwind, right? We're not alone in these markets. We have to be better than our competitors. But I think we – restructured this business. We've sold off some businesses that my answer would be a lot different if we still had those businesses. They were in cyclical decline, dated product portfolios, you know, ultra, ultra competitive markets. There were a heck of a lot of headwinds there. So we've released the company of many of these systemic headwinds. But listen, there's always competition. There's always potential changes in legislation. which could create disruption in the business. But by and large, I think we've really fine-tuned the portfolio to be in those categories, food and personal care, where there is just simply an, there is always an underlying need to have these products. I may not need to buy a car, but I need to eat. I may not need to buy a house, but I need to drink. And I think that type of
spk01: market is really why sentient is the right type of company to be invested in and to be looking at because Those are the types of fundamentals that we have as a fixture of being in these markets Okay, no, that's very helpful Just switching gears a little in terms of capital allocation obviously Given the debt level interest expense certainly an issue this year just curious in terms of the focus on debt reduction versus maybe exploring additional potential opportunities like endemics and how should we think about that?
spk00: So Mitra, I think on capital allocation, our top priority is internal investment in the, in the company right now. We've got some good projects. As Paul mentioned, we're very happy with our portfolio and we believe there's a lot of areas there to, invest for growth and savings. So that's our first priority. Beyond that, in terms of M&A, I would expect that we would continue to look at bolt-on M&A. So things like the acquisition that you mentioned. So sort of smaller add-on deals that might bring a technology or a supply chain advantage. And then the excess at this time would go towards debt reduction because of the interest rate environment that you that you pointed out.
spk01: Okay. That's it for me. Thanks for taking the questions.
spk04: Okay. Thank you, Mitra.
spk05: And the next question is from David Green from Baldhaven. Please go ahead.
spk02: Hi, Steven. How are you doing?
spk04: Hello, David. I was wondering when you were going to show up.
spk02: I'm still here.
spk04: All right.
spk02: Just a couple of questions first. From me, I guess on F&E specifically, you talked about a couple of dynamics, one which is clearly DTOC, and the other one that you alluded to was end market demand. So it would just be really helpful to get a little bit more color on what that is specifically. And then within F&E specifically, just any color you could give us in terms of momentum and in terms of new wins and what the pipeline looks like there. And I'll just start off with those two, if that's okay.
spk04: Okay. So end market demand. Hang on. Let me grab my sheet so I can read a few things off to you here. Q1, you know, again, as many of our customers are increasing prices, you can see that their volumes are down. And this is where I think perhaps many of them are making the tradeoffs between pricing and volume. And so certainly that plays out for us when we're selling into some of those segments where customers may be trading down or whatnot. you see some temporary declines in a number of these categories. So, for example, soup was down quite a bit for the year and for the quarter, right? Not unusual given how much that had grown during the course of the pandemic. But, you know, something like pet food, dog food, frozen and refrigerated, you know, it's growing unabated for the year, for the quarter. We're seeing some nice improvement or, shall I say, recovery in the confectionery world. But then again, on the beverage side, right, energy drinks are way up, but a lot of the other categories of beverage are down a touch in the course of Q1. So, you know, these are temporary phenomenon owing to, again, a lot of the activity around pricing with many of the brands. And so I think the longer-term prospects here are good as end customers sort out where they're going to spend their money and where prices settle out at. So that's harder to predict, but certainly you can see some of the hot categories during the pandemic are kind of coming back to earth. And, you know, many of the traditional beverage categories that folks have expressed a lot of interest in over the last number of years are coming back to maybe some of the pre-pandemic levels. As you think about our business and to your question about momentum and pipeline, you know, I spend a lot of time focusing on the things that I can control. I can control our new win rate, right? How much are we winning? Do we have enough salespeople to go get those wins? Are we servicing those customers to get those wins? Do we have enough customers to continue to generate those wins? And the new wins are very, very good. As I mentioned last year, we had a great year of new wins in flavors. And that trend is continuing. Very, very broad-based, whether you're talking about dairy or you're talking about beverage, a lot of opportunities for us still ahead. And so to your question about the pipeline, yeah, there again, for the pipeline, we are very, very aggressive, and I'm very, very demanding that our salespeople are out there and they are generating new business and they're servicing the hell out of their customers. And so this is not a place for a salesperson to kind of come and hang out and sort of not get noticed. That doesn't happen here. And if it does, it doesn't happen for very long. So a lot of this comes down to the effectiveness of managing a sales force and the demands that we place. And then, of course, the rewards that we give for success. We have a very high tolerance for success in this company, and we reward those folks, I think, very, very well. which speaks to retention of the very good people. And so I think a lot of the momentum is brought to you by very, very good salespeople, very good back office folks supporting them on the customer service metrics that are the most meaningful. And again, that drives the pipeline into my point earlier about the increase of new launches. That's a really awesome dynamic as we get into 2023.
spk02: And the increase in new launches, is that across both colors in F&E or more specifically to either one of those?
spk04: Well, I would tell you this. The new launches in color are bigger. We had some natural color wins that were quite outsized. Of course, we also had some synthetic color wins that were quite outsized. As you know, The color group has a very broad range of customers from the biggest to the smallest that we sell to. And so with this ongoing conversion to natural colors, you can hit some pretty big wins when you have the right technology and the right service levels and all those other factors. And so we also see really good wins in flavors. And I would tell you it's actually fairly broad-based, the wins. maybe a little bit lighter and savory for the last few months than, say, something like beverage or sweet flavors. But nevertheless, the wins are pretty well represented throughout the portfolio.
spk02: Great. And then two more questions, if I can. One was just on colors and margins specifically. What we've seen so far is that there's probably been a bit less operating leverage than we would have expected given the strength in top line. And your comments around that had been that the raw material costs weren't fully covered by pricing. It feels like there was a little bit more operating leverage coming through this quarter. Is there any signs that that's normalizing now and we should see a bit more operating leverage going forwards?
spk04: So the answer is you should continue to see improvement in the operating leverage. As Steve noted, or maybe I noted in the prepared remarks, a lot of this has to do with the timing. When you get the input costs and when you successfully negotiate those pricing increases, there could be a lag. Now, if inflation was kind of a one-and-done or a one-time thing, you'd see the operating leverage catch up much faster. But when inflation is an ongoing thing, and you can be chasing costs in certain categories and with certain customers, you may see that delay. So what that improvement in the operating leverage that you noted speaks to is, if nothing else, inflation's at least staying at the elevated level, and the slope is not ascending further, but it's certainly not, in any broad sense, decelerating. Color was just a It was here splittingly close to 20%, so I feel really good about their profit levels. But as the year progresses, and again, if inflation holds here and potentially even recedes a little bit, yeah, you'll see an even nicer improvement in the operating leverage of the color group.
spk02: Great. And one final one for me on APAC. I think every time... we ask you this question, you sort of reply in the same way, which is how long can this level of growth continue for? And I think you always say, look, it's going to be really hard to carry on growing at this level and margin improvement associated. And yet you're sort of still consistently delivering this sort of, you know, above double digit kind of growth rate. you know, how should we really be thinking about that business and how do you think about the sort of growth and growth cadence going forward?
spk04: Well, I think we've got, there's a lot of people in Asia. I notice that every time I go there. And so I think it's a really big market with a lot of opportunities for us. Regional companies, local companies, in many cases, they are commanding the markets. They are not markets that are in all cases, led by these large multinationals that you see, for example, in Europe and the U.S. So it's a little bit more of a broader customer base. And so I think that's been quite helpful. You don't necessarily have that constraint within the flavor sales of core listings. Sure, multinationals are there and they have core listings, but A lot of the regional guys here at the Bay, they don't have core listings. They have people they deal with, and they deal with the best producer. And they're perhaps not wedded to history, as you may see in other parts of the world. So we got great people in Asia. We got great leadership in Asia. And I think that counts for a lot. So we've got it mid to high on top line. I'd like to think that is sustainable for a number of years into the future. We've been, like, well above that, and that's pretty awesome. But I think, hey, that look at Q2 looks pretty darn good as well, and I think the year is going to be great. But I think, you know, mid to high is a good sort of long-range framework to think about as you're thinking about Asia Pacific's top-line growth.
spk02: And so the 14.6, if we break it down into volume and price, what would that mix have been?
spk04: Um... A little bit better than 50% of that was volume.
spk02: Great. Thanks again. Okay, David. Take care.
spk05: Ladies and gentlemen, there are no further questions at this time. I will turn the conference back to the company for any closing remarks.
spk00: Okay. Thank you, everyone, for tuning in today. That will conclude our call. Thank you.
spk05: The conference has concluded. You may now disconnect.
Disclaimer